Catalyst Pharmaceuticals (CPRX) Change in Account Payables (2010 - 2026)
Catalyst Pharmaceuticals' (CPRX) quarterly Change in Account Payables came in at -$4.1 million in Q1 2026, up 24.93% YoY from -$3.2 million in Q1 2025, and down 292.36% on a QoQ basis from $2.1 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Change in Account Payables (2010 - 2026) Analysis & Trends
Catalyst Pharmaceuticals (CPRX) has 17 years of Change in Account Payables data on file, last reported at -$4.1 million in Q1 2026.
- Quarterly Change in Account Payables rose 24.93% year-over-year to -$4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.0 million (down 532.26% YoY) and the FY2025 annual result came in at -$5.4 million, down 399.83% from the prior year.
- Change in Account Payables eased to -$4.1 million in Q1 2026, from $2.1 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $10.2 million in Q4 2023 to a low of -$5.7 million in Q2 2025.
- A 5-year average of $257823.5 and a median of $214000.0 in 2022 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 8937.5% in 2022, down 873.7% in 2022.
- Tracing CPRX's Change in Account Payables over 5 years: stood at $1.4 million in 2022, then jumped by 605.19% to $10.2 million in 2023, then sank by 50.67% to $5.0 million in 2024, then tumbled by 58.13% to $2.1 million in 2025, then plunged by 292.36% to -$4.1 million in 2026.
- The last three Change in Account Payables figures came in at -$4.1 million (Q1 2026), $2.1 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | -4.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.05 Mn |
| Mar 31, 2026 | -4.05 Mn |
| Dec 31, 2025 | 2.11 Mn |
| Dec 31, 2025 | 2.11 Mn |
| Sep 30, 2025 | 3.57 Mn |
| Sep 30, 2025 | 3.57 Mn |
| Jun 30, 2025 | -5.67 Mn |
| Jun 30, 2025 | -5.67 Mn |
| Mar 31, 2025 | -5.40 Mn |
| Mar 31, 2025 | -5.40 Mn |
| Dec 31, 2024 | 5.03 Mn |
| Dec 31, 2024 | 5.03 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | -3.15 Mn |
| Jun 30, 2024 | -3.15 Mn |
| Mar 31, 2024 | -4.53 Mn |
| Mar 31, 2024 | -4.53 Mn |
| Dec 31, 2023 | 10.20 Mn |
| Dec 31, 2023 | 10.20 Mn |